Home > Healthcare > Pharmaceuticals > Finished Drug Form > Acne Medication Market
Acne Medication Market Share
- Report ID: GMI3010
- Published Date: Nov 2022
- Report Format: PDF
Acne Medication Market Share
Major enterprises operating in the acne medication sector are:
- Allergan (AbbVie)
- Galderma S.A
- Reckitt Benckiser Group plc
- Bausch Health
- Stiefel Laboratories (GlaxoSmithKline plc)
- Bayer AG
- Almirall SA
- Paratek Pharmaceuticals
- Teva Pharmaceutical Industries
- Akorn Operating LLC
- Sun Pharmaceuticals
- Pfizer Inc
- Viatris
- Mayne Pharmaceuticals
- Procter & Gamble.
Frequently Asked Questions (FAQ) :
Global market size for acne medication crossed USD 9.9 billion in 2022 and is expected to observe over 5.5% CAGR from 2023 to 2032 owing to a rising prevalence of severe acne issues.
Oral segment is projected to depict over 6% CAGR from 2023 to 2032 due to the high efficacy of oral formulations in minimizing bacterial outgrowth and treating severe and inflammatory acne.
Pharmacies and drug store segment is expected to depict a growth of over 5.5% between 2023 and 2032 owing to the continuous efforts by leading industry participants to expand their pharmacy and drug store network in remote locations.
Europe acne medication market is poised to amass over USD 2.4 billion by 2032 driven by improving economic growth, rising disposable incomes, and increased consciousness about facial aesthetics.
Acne Medication Market Scope
×
Get a free sample of
Acne Medication Market
Inquiry Before Buying
Get special pricing options on this report
Request Sectional Data
Over 70% of our clients customize reports to fit their needs. Please tell us how you would like to customize yours
below